Anticipation of imminent REGAL Phase 3 AML readout drives SLS
Anticipation of imminent REGAL Phase 3 AML readout drives SLS 18% surge
- As of May 11 2026 REGAL trial of GPS in AML maintenance had reached 78 of 80 required events triggering final analysis upon the 80th
- No new company press release on June 25 but time elapsed since May update has heightened expectations that the 80th death event is near
- Retail chatter on Reddit X and forums plus heavy call option activity amplified momentum with traders citing "data any day"
- Stock broke above $10 hitting multi-week highs extending gains from Cramer endorsement and May trial progress update
- Breakout occurred on elevated volume in small-cap biotech with pending binary catalyst for GPS in high-risk AML patients
- Minor 8-K filed updating executive change-of-control severance but not viewed as primary driver
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.